JoltooJoltoo
Grants
Browse catalogTailored listsFind your matchesFundersPrograms
InvestorsAdvisoryInsights
DeepTech 2026 PlaybookGet started free
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Curie.Bio
Curie.Bio

Curie.Bio

Pure DeepTechBoston, United StatesActiveWebsiteLinkedIn
Stage FocusSeed
GeographyUS
TypeAccelerator/VC
Last Activity2025
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio

Curie.Bio combines a founder-focused seed-stage VC with an industry-grade therapeutics accelerator. Total capital approaches $1B — a $520M initial fund, a $380M Series A fund, and a $340M+ Seed Fund II. Founded by Alexis Borisy, Christoph Lengauer, Tom Hotchkiss, and Zach Weinberg, the firm writes $7-12M seed investments per company.

The 50-person team includes drug hunters and biotech operators,...

Similar Funds

3E Bioventures Capital

3E Bioventures Capital

China

Pure DeepTechBiotechMedtechSeedSeries A
5H

5 Horizons Ventures

Oklahoma City, United States

Pure DeepTechBiotechSeedSeries A
Advent Life Sciences

Advent Life Sciences

London, United Kingdom

Pure DeepTechBiotechMedtechSeedSeries A
Alix Ventures

Alix Ventures

San Francisco, United States

Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
Apollo Health Ventures

Apollo Health Ventures

Berlin, Germany

Pure DeepTechBiotechSeedSeries A
ARCH Venture Partners

ARCH Venture Partners

Chicago, United States

Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
Work at Curie.Bio? Claim this page
JoltooJoltoo
PricingInsightsTailored lists
Privacy PolicyTerms of Service
Security
© 2026 Joltoo. All rights reserved.